Background: Evidence of the value of systematically collecting family history in primary care is limited.
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F
amily history is a recognized risk factor for many chronic diseases (1) and is traditionally part of history taking in clinical practice (2) . However, a recent National Institutes of Health State-of-the-Science conference (2, 3) identified the need for evidence, from controlled trials, on the value of systematically collecting and using family history in primary care. Family history is rarely used in isolation but instead is part of a multifactorial risk assessment, such as for coronary heart disease (CHD). The Joint British Societies 2 (JBS2) cardiovascular risk assessment guidelines use the Framingham algorithm and are widely adopted in the United Kingdom (4 -6) . The cardiovascular risk prediction charts in these guidelines (5) use the core cardiovascular factors of age, sex, smoking status, systolic blood pressure, and ratio of total to high-density lipoprotein (HDL) cholesterol levels. However, family history of premature CHD can also be subjectively incorporated at the clinician's discretion. Like the U.S. National Cholesterol Education Program Adult Treatment Panel III guideline (5, 7), the JBS guidelines define a significant family history as CHD in a male first-degree relative younger than 55 years or a female first-degree relative younger than 65 years.
Available observational epidemiologic studies (8, 9) suggest that adding family history might identify more than 60% of persons who have the greatest risk for CHD and who might benefit from preventive care. However, experimental evidence from pragmatic randomized trials is required to evaluate the effect of family history interventions and the feasibility of implementing them in usual primary care practice (2, 3) . During consideration of appropriate interventions, it should be recognized that family history is poorly recorded in electronic health records in family practice (10, 11) . A more systematic approach to collecting family history is needed to improve identification of significant familial risk. Self-administered family history questionnaires may provide a solution (12, 13) .
Two key questions arise for clinicians and policymakers. First, in a healthy population that accepts an invitation to cardiovascular risk assessment, how feasible is it for primary care physicians to collect more detailed family history information? Second, if such information is collected and used systematically, how many more persons at high risk for cardiovascular disease will be identified? We compared an intervention in which family history of premature CHD was systematically collected and incorporated into cardiovascular risk assessment in primary care with risk assessment based on usual practice. We hypothesized that systematically collecting family history in family practice would improve identification of persons with undiagnosed high cardiovascular risk. We also explored any effect on participant anxiety and potential changes in self-reported behavior.
METHODS
Our trial methods have been described in detail elsewhere (14) . The hypotheses were tested in a pragmatic, matched-pair, cluster randomized, controlled trial between July 2007 and March 2009. Ethical approval was obtained from a United Kingdom Medical Research Ethics Committee (reference 06/MRE10/9).
Setting and Randomization
All family practices in the research networks of the central and southwestern regions of England were contacted. To prevent an imbalance between control and intervention groups, eligible practices that were willing to participate were matched into pairs according to United Kingdom Index of Multiple Deprivation score and ethnicity (Ͻ10% or Ն10% ethnic minorities originating from the Indian subcontinent), as recognized risk factors for CHD (5, (15) (16) (17) . One practice in each pair was randomly assigned to the family history intervention group and the other to the control (usual care) group by using the Webbased randomization service of the Nottingham Clinical Trials Unit, Nottingham, United Kingdom. Randomization was stratified by the 2 regions. Physicians were aware of the intervention used in their own practices but not in other practices. For practical reasons, we could not blind research fellows; however, the primary outcome was an objective measure obtained from a predefined algorithm (JBS2 risk calculator), and secondary outcomes were selfreported by participants. The data entry clerks and statisticians were blinded to group assignment until all analyses had been completed.
Before participant recruitment, research fellows facilitated a standardized training session at each practice. For both groups, this involved the use and interpretation of cardiovascular risk scores and current public health recommendations for lifestyle advice (5) . In the intervention group, clinicians were given information on interpreting and communicating the risk associated with a family history of premature CHD, on the basis of a pilot study (18) .
The standard cardiovascular risk score is calculated by inputting core risk factors (age, sex, smoking status, systolic blood pressure, and total-HDL cholesterol ratio) into the cardiovascular risk calculator. This score was multiplied by 1.5 if a family history of premature CHD was identified (5). Appendix 2 (available at www.annals.org) provides further details.
Participants and Recruitment
To be included, participants had to be aged 30 to 65 years and had to request or be offered a cardiovascular risk assessment by their family physician, as per usual practice. Participants were excluded if they had previously diagnosed diabetes or atherosclerotic disease (CHD, stroke, or peripheral vascular disease), were already receiving lipidlowering medications, or were excluded by their family physicians for psychological or social reasons.
The initial cardiovascular risk assessment consultation was similar across sites, with the family physician or office nurse checking for exclusion criteria in the JBS2 cardiovascular risk assessment, measuring blood pressure, and documenting smoking status (Appendix 2). Serum cholesterol samples were collected by local phlebotomy services. The physician or nurse also checked study exclusion criteria and gave eligible participants an invitation letter, consent form,
Context
Information about a patient's family history can improve risk assessment for cardiovascular disease.
Contribution
This cluster randomized trial, which involved 748 adult patients with no previously diagnosed cardiovascular risk across 24 family practices, found that collecting family history data with mailed questionnaires identified more highrisk patients who were eligible for targeted prevention than did usual practice procedures (4.8% vs. 0.3%).
Caution
Effect on long-term clinical outcomes of patients was not evaluated.
Implication
Systematic collection of family history data is a feasible practice-level intervention that could improve cardiovascular risk assessment and help target patients who are most in need of preventive interventions.
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Original Research Collecting Family History to Assess Risk for Cardiovascular Disease information leaflet, study questionnaire for secondary outcomes, and a family health questionnaire (intervention group only). Consent included access to participants' electronic health records to extract anonymized data on family history information, other cardiovascular risk factors, investigations, and medication. Two weeks after the consent forms were returned to the research office, practices were contacted to confirm the eligibility of potential participants and to gather data on core cardiovascular risk factors.
Interventions
Participants in both groups received standard cardiovascular risk assessment for core risk factors (5) . In the intervention group, family history of CHD was also systematically collected by using a self-administered questionnaire at recruitment and this was incorporated into the risk assessment score (5) .
The self-administered family history questionnaire was designed to collect information in primary care on cardiovascular disease, cancer, and reproductive carrier status (12, 19) . This tool has been successfully validated and demonstrated 90% agreement in identification of family history of premature CHD with a criterion standard (clinical genetic 3-generation pedigree-drawing interview) and with confirmation of face and content validity from participants and family physicians (10, 12) . The questionnaire was further tested with family practices that performed cardiovascular risk assessment (18) . The questionnaire covers personal medical history, details of CHD in parents and grandparents, and family size (number of siblings, offspring, uncles, and aunts). Further sections are completed if participants recall any relatives listed in the family size section who had heart disease or died.
The cardiovascular risk scores were calculated by research fellows. The results were then sent back to the participants, along with a lifestyle advice leaflet, within 4 weeks of the original assessment. A duplicate copy was also sent to the family physician. Consistent with usual clinical practice, all participants who had a 20% or greater risk for cardiovascular disease over the next 10 years were offered an appointment to see their family physician or office nurse about 2 weeks after the result letter was posted. In this consultation, the increased risk was explained and lifestyle advice was offered. In the intervention group, the effect of a family history of premature CHD on cardiovascular risk was also discussed.
Outcomes and Follow-up
To determine the feasibility of using the family history questionnaire, we calculated the response and completion rates. The former was defined as the proportion of participants assigned to the family history intervention group who returned the questionnaire; the latter as the proportion of participants who entered information on their family size and their parents or grandparents.
The primary outcome measure was proportion of participants classified as having high risk for cardiovascular disease (10-year risk Ն20%). The electronic health records at each practice were reviewed to identify available data on family history of premature CHD and to extract anonymized data on other cardiovascular risk factors, investigations, medication, and newly diagnosed CHD.
For all participants, secondary outcome measures were assessed at baseline and 6 months by using a selfadministered questionnaire to collect information on anxiety (6-item Spielberger State-Trait Anxiety Inventory), smoking, exercise (stage of change), and fat intake (19 -23) . Full details are described elsewhere (14) .
Sample Size
The sample size for the primary outcome measure was based on a comparison of the change in the percentage of participants classified as having high cardiovascular risk between study groups. This assumed that the proportion of participants identified as having high cardiovascular risk would increase by 3 percentage points in the family history intervention group and would not increase in the control group, based on usual practice at the start of the study (10) . Assuming a power of 80% and a 2-tailed ␣ of 5%, 265 participants per group were required to detect a difference of 3 percentage points. To allow for the cluster design, we assumed an intraclass correlation coefficient of 0.01 and a cluster size of 40. This gave a sample size of 369 participants per group completing cardiovascular risk assessment (10 practices per group).
Statistical Analysis
Analysis was undertaken on an intention-to-treat basis because practices (and thus participants) were analyzed in the groups to which they were randomly assigned. The time points of interest were immediately after the cardiovascular risk score calculation for the primary outcome measure and 6 months after the intervention for the secondary outcome measures. The primary comparison was the difference in the increase in the proportion of participants classified as having high cardiovascular risk in the intervention practices (with addition of systematic family history in cardiovascular disease assessment) compared with control practices. This comparison was calculated twice, first without taking account of available family history in electronic health records in the control group and, second, with the family history information included. Family history of CHD was assumed to be negative if no information on family history was available in the electronic health record. For the secondary outcomes of anxiety score, exercise, and dietary intake, the 6-month follow-up measures were compared between the groups. For smoking, change between baseline and 6-month follow-up was compared. Two statisticians performed independent analyses by using STATA, version 11.0 (StataCorp, College Station, Texas).
Similar to other studies with matched-pair designs (24 -26) , primary and secondary outcomes were compared between groups by using a 2-stage procedure. In the first stage, we adjusted for practice-and participant-level vari- ables. In the second stage, we tested for the intervention effect-that is, the difference in event rates (for example, the mean increase in proportion of participants at high cardiovascular risk)-between the intervention and control group pairs. In the first stage, we fitted a logistic model containing practice-and patient-level covariates but no intervention indicators. We used the residuals obtained from this model (the difference between the predicted outcome rate and the observed outcome rate for each practice) in the second stage of the analysis, in which we applied the weighted paired t test to the difference between the residuals corresponding to the practices in a matched pair to test for the intervention effect. The number of participants in each practice pair was used as the weights in this analysis. If the assumptions of the paired t test were not met, an unweighted Wilcoxon matched-pairs signed rank test was used instead. A permutation test was used to assess the robustness of the t test (27) . All analyses were adjusted for resident training status of practice, a proxy measure of practice workload, and the ethnicity and educational status of the participants. Both practice variables would affect the family physicians who offered opportunistic cardiovascular risk assessment, and the participant variables would increase cardiovascular risk (5, 15-17, 28 -30) . Secondary outcomes were also adjusted for baseline measures, and the participant variables used to calculate the cardiovascular risk score (such as sex) were adjusted for by the inclusion of baseline cardiovascular risk in the models. In the analysis of secondary outcomes with high proportions of missing values, the values were replaced by using the ICE command in STATA to carry out multiple imputation of all predictor variables in the model (10 imputations).
Role of the Funding Source
Our study was funded by the Genetics Health Services Research program of the United Kingdom Department of Health. The funders and sponsors did not participate in the design or conduct of this study, analysis or interpretation of data, or writing of or decision to submit the manuscript for publication.
RESULTS
Of the 33 practices that expressed interest, 2 were outside the geographic area. The remaining 31 practices used the JBS2 risk assessment tool to assess cardiovascular risk. After receiving further study information, 7 practices declined to participate (1 practice already incorporated family history in risk assessment). The remaining 24 practices did not use family history in cardiovascular risk assessment and were divided into 12 pairs (6 in each region).
Overall, 748 eligible participants were recruited from the 12 pairs of family practices. Practices and participants in both groups had similar characteristics, apart from a higher proportion of male and Asian participants in the intervention group (Tables 1 and 2 ).
Study Progress
The Figure summarizes participant flow through the study. All practices received the intervention to which they were allocated, and none of the practices withdrew after recruitment. A total of 1828 recruitment packs were distributed to the 24 practices (915 to the intervention group and 913 to the control group). The recruitment rates were 45.0% (412 consenting participants) in the intervention group and 41.6% (380 consenting participants) in the control group. In the multivariate analysis of the primary outcome measure, 13 participants were excluded because of missing covariate data (ethnicity or education) and an additional 110 were excluded for the secondary outcome measures because they did not return the final study questionnaire.
The response rate to the 6-month questionnaire was 86.6% (310 of 358 participants) in the control group and 84.1% (328 of 390 participants) in the intervention group. For the 105 participants identified as having high cardiovascular risk, the median time between posting the results letter and the date of consultation was 12 days (interquartile range, 7 to 16.5 days). The initial offer of a consultation was accepted by 27 participants (75%) in the control group and 48 (69.6%) in the intervention group.
Of the 412 participants in the intervention group, 7 did not return their family history questionnaires, for a response rate of 98.3%. Among the 405 participants who returned the questionnaire, 18 (4.4%) did not complete IQR ϭ interquartile range. * Calculated by dividing the number of patients registered by the number of physicians and nurses in a practice. † A British scoring system for the level of social deprivation based on aggregating 7 weighted measures of deprivation (income deprivation, employment deprivation, health deprivation and disability, education, skills and training deprivation, barriers to housing and services, and living environment deprivation and crime) in the specified postal code (in this case, that of the family physician's office).
Original the family size section and 19 (4.7%) provided no information on the age or medical history of their parents or grandparents. Overall, 24 questionnaires (5.9%) had at least 1 incomplete section and were considered poorly completed.
Primary Outcome Measure
The primary outcome measure was analyzed for 735 (98.3%) of allocated participants (Figure) . Table 3 shows the proportion of participants at high cardiovascular risk after standard cardiovascular risk assessment (control group) and enhanced cardiovascular risk assessment incorporating systematically collected family history of premature CHD (family history intervention group). For participants in the intervention group, the percentage of participants at high risk increased by 5.1 percentage points, compared with a 0.5-percentage point increase in the control group when family history from electronic health records was incorporated. The number of participants at high risk in the intervention group increased from 49 to 69 (40.8%) after family history from the questionnaire was incorporated, compared with a 5.6% increase in the control group (from 36 to 38 participants).
Across the intervention practices, the percentage of participants at high cardiovascular risk increased by a mean (Table 3) , compared with a mean increase of 0.3 percentage point in the control practices when family history from electronic health records was incorporated. Thus, the mean difference between study groups was 4.5 percentage points (95% CI, 1.7 to 7.2 percentage points) when family history from the control group was incorporated and 4.8 percentage points (CI, 2.0 to 7.7 percentage points) when it was excluded. After adjustment for participant-and practice-level variables, the difference between groups was significant (P ϭ 0.007 when incorporating family history from the control group; P ϭ 0.005 when excluding it). The P value of the permutation test was identical to that obtained from the original analysis, which confirms the results of our original paired t test (27) . Table 4 presents the proportion of all participants with a family history of CHD in each group, regardless of the cardiovascular risk status of the participant. About 5% of participants in each group (5.9% in the control group vs. 5.4% in the intervention group) had a family history of premature CHD recorded in their health records, which increased to 29.2% in the intervention group when information from the family history questionnaire was added. In both groups, more than 50% of electronic health records had no information on any positive or negative family history of CHD.
Secondary Outcome Measures
Appendix Table 1 (available at www.annals.org) summarizes secondary outcome measures at baseline and at 6-month follow-up. In the multivariate analysis, multiple imputation was used to replace missing values for these outcomes because of the high proportion of participants with missing data (anxiety, 180 participants [24%]; stage of exercise, 142 participants [19.0%]; total fat intake, 607 [81.1%]). Study groups did not significantly differ in anxiety levels or any other outcome measure (Appendix Table  2 , available at www.annals.org). Because of the small number of smokers at baseline, multiple imputation was not performed. Among participants who smoked at baseline and who completed the 6-month questionnaire, none in CVD ϭ cardiovascular disease. * Risk for CVD over 10 y calculated from risk factors of age, sex, smoking, systolic blood pressure, total cholesterol level, and high-density lipoprotein cholesterol level by using the Framingham-based Joint British Societies 2 algorithm. † Risk for CVD over 10 y calculated by using the Framingham-based Joint British Societies 2 algorithm and incorporating family history obtained from electronic health records for the control group and from completed family history questionnaires for the intervention group. ‡ Mean difference between matched pairs of control and intervention group practices (intervention minus control).
§ From multivariate analysis with adjustment for practice-level variables (practice involved in resident training and patient workload) and patient-level variables (ethnicity and highest level of education or professional qualification).
Mean difference in the increase in the proportion of participants at high risk resulting from family history being accounted for (using family history questionnaires in only the intervention group) between matched pairs of practices. ¶ Mean difference in the increase in the proportion of participants at high risk after accounting for family history (using family history questionnaires for the intervention group and data from electronic health records for the control group) between matched pairs of practices. CHD ϭ coronary heart disease. * Using Joint British Societies 2 criteria for a family history of premature CHD (diagnosis of CHD in Ն1 male first-degree relative younger than 55 y or Ն1 female first-degree relative younger than 65 y). † Recording of any family history of CHD (premature or nonpremature). ‡ Recording that the person has no family history of CHD. 
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DISCUSSION
We found that adding systematic collection of family history improves the identification of persons with high cardiovascular risk in primary care practice. Compared with practices that offered the usual Framingham-based assessment, the intervention practices identified an additional 5% of persons with high cardiovascular risk. The substantial participant response and completion rates suggest that collecting the necessary family history data by using a self-completed questionnaire is feasible.
To our knowledge, ours is the first controlled trial to evaluate the clinical utility of systematically collecting family history as part of a multifactorial cardiovascular risk assessment in primary care (3, 15) . This use within a multifactorial assessment of clinical risk to inform preventive clinical intervention adds to existing evidence from standalone assessments of family history for identifying familial risk for cancer, diabetes, and cardiovascular disease (3, 15, (31) (32) (33) .
The number of persons classified as having high cardiovascular risk increased by 41% in the intervention group (from 49 to 69), compared with a 6% increase in the control group (from 36 to 38), after family history available in electronic health records was taken into account. The persons identified would originally have been classified as having moderate cardiovascular risk (10-year risk of 10% to 19%) and would not be considered for statins or aspirin (5) . Being identified as having high cardiovascular risk would justify targeting of intensive lifestyle change and preventive medication. In particular, statins could costeffectively reduce future CHD events by more than 30% in these persons (34 -37) . Consistent with previous work (3, 19, 31) , our intervention did not lead to undue anxiety.
Our trial benefited from minimal missing cases for primary outcome measures and a high response rate to study questionnaires. To improve generalizability and anticipate implementation in practice, we used a pragmatic intervention and process for cardiovascular risk assessment that reflected procedures currently used in clinical practice.
Our prior pilot work (12, 18) indicated that recording family history of CHD is very limited in practice. As confirmed at practice recruitment, it was also uncommon for family physicians to incorporate family history into cardiovascular risk assessment, even when this information was available in electronic health records (18) . Thus, our original primary outcome measure compared cardiovascular risk assessment using systematic collection of family history with assessment involving no family history information. However, the potential value of family history in cardiovascular risk assessment has recently become more prominent in primary care practice and policy in the United Kingdom (38, 39). Thus, our revised primary outcome measure compared cardiovascular risk assessment that included systematically collected family history with an assessment that took family history available in patient records into account. Our study confirms that using the latter method only minimally increases the proportion of participants identified as having high cardiovascular risk. Moreover, a large proportion of records contains no information on family history at all. As definitions of relevant family history of CHD for risk assessment tools become more complex, systematic recording of family history will probably increase in importance; our findings further support this (16, 39, 40) .
One of the greatest limitations to implementing systematic family history enquiry is its collection within the health consultation itself. Our findings suggest that collating and summarizing the information before the consultation might facilitate its use in cardiovascular risk assessment or in other clinical contexts. For example, these data could be collected when a person registers with a family practice (12, 19) and inserted into electronic health records by using predefined codes for relevant family histories (41) . In the future, online questionnaires, similar to the Webbased Surgeon General's Family Health Portrait tool (42), could be developed.
Using a cluster randomized design reduced the risk for contamination between groups, whereas using matched pairs helped preserve power by reducing the imbalance between groups. We acknowledge that a relatively small proportion of less-educated persons and members of ethnic minority groups were recruited, and that higher selfreported levels of risk-reducing behavior at baseline may affect the generalizability of our study (43) . Further, the intervention was not designed to change participant behavior. However, the potential for any effects on lifestyle was explored to inform future interventions (44) . This had several limitations, including follow-up of only 6 months and use of self-reported information and data extracted from electronic records, both of which had missing values. Our study therefore lacks clinical outcome data.
No major or statistically significant changes in participants' risk-reducing behaviors were identified. Other studies (43, 45) have produced mixed findings: A combined familial risk assessment for cardiovascular diseases and canOriginal Research Collecting Family History to Assess Risk for Cardiovascular Disease cer demonstrated moderate improvement in self-reported dietary intake and physical activity, whereas another study showed that participants reported a healthier diet after identification of familial diabetes risk. Although use of family history may assist in directing preventive efforts to persons at greatest cardiovascular risk, further research could assess whether more intensive interventions, including counseling that emphasized familial predisposition, would improve objectively measured risk-reducing behavior and clinical outcomes.
Compared with universal screening of untreated persons, recent modeling suggests that using a targeted strategy to identify about 60% of the population at highest risk could prevent almost all cardiovascular disease (8, 46) . Our study shows that using systematic family history information increases the proportion of persons who can be identified as having the highest cardiovascular risk in the general primary care population. Although we did not compare targeted screening with universal screening, our findings highlight the promising role that greater use of systematic family history collection could play in a targeted strategy in primary care. This potentially low-cost approach also seems feasible in practice and is acceptable to patients.
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